These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8422147)

  • 1. Can efficiency of follow-up for superficial bladder cancer be increased?
    Gulliford MC; Petruckevitch A; Burney PG
    Ann R Coll Surg Engl; 1993 Jan; 75(1):57-61. PubMed ID: 8422147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nonlinear optimization for scheduling of follow-up cystoscopies to detect recurrent bladder cancer. The Bladder Cancer follow-up Group.
    Kent DL; Nease RA; Sox HC; Shortliffe LD; Shachter R
    Med Decis Making; 1991; 11(4):240-8. PubMed ID: 1662739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial bladder cancer: timing of check cystoscopies in the first year.
    Morris SB; Shearer RJ; Gordon EM; Woodhouse CR
    Br J Urol; 1993 Oct; 72(4):446-8. PubMed ID: 8261301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
    Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
    Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].
    Werner W; Smesny S; Schubert J
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):519-27. PubMed ID: 10996943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer.
    Koya M; Osborne S; Chemaslé C; Porten S; Schuckman A; Kennedy-Smith A
    BMC Urol; 2020 Feb; 20(1):12. PubMed ID: 32046687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of superficial bladder cancer: how to spare cystoscopies?
    Vera-Donoso CD; Llopis B; Oliver F; Server G; Alonso M; Jimenez-Cruz JF
    Eur Urol; 1990; 17(1):17-9. PubMed ID: 2180718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of regular biopsy in the first cystoscopic follow-up and other predictors on the recurrence of superficial bladder tumors.
    Chang YH; Chuang CK; Pang ST; Wu CT; Chuang KL; Liao SK
    Chang Gung Med J; 2010; 33(2):174-87. PubMed ID: 20438670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
    BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of bladder tumour treatment and follow-up.
    Hedelin H; Holmäng S; Wiman L
    Scand J Urol Nephrol; 2002; 36(5):344-7. PubMed ID: 12487738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database.
    Mariappan P; Smith G
    J Urol; 2005 Apr; 173(4):1108-11. PubMed ID: 15758711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    Kamat AM; Karam JA; Grossman HB; Kader AK; Munsell M; Dinney CP
    BJU Int; 2011 Oct; 108(7):1119-23. PubMed ID: 21426474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study.
    Couffignal C; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Mentre F; Cussenot O; Grandchamp B
    Urology; 2015 Dec; 86(6):1185-90. PubMed ID: 26364695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.
    Andius P; Holmäng S
    BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial bladder cancer: for how long should a tumour-free patient have check cystoscopies?
    Morris SB; Gordon EM; Shearer RJ; Woodhouse CR
    Br J Urol; 1995 Feb; 75(2):193-6. PubMed ID: 7850325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.